Drug Trial Radar · NCT06786338
A Study of SGB-9768 in Patients With Complement-mediated Kidney Diseases
Last checked: Nov 20, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
45
Actual
Start
Jun 6, 2025
Primary completion
Dec 29, 2026
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- Suzhou Sanegene Bio Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study looks at how well and safely SGB-9768 works for patients with certain kidney diseases: primary IgA nephropathy, C3 glomerulopathy, and immune complex-related membranoproliferative glomerulonephritis. It's a phase 2 trial done at several locations where both patients and doctors know what treatment is being given.
Conditions
- IgA Nephropathy (IgAN)
- C3 Glomerulopathy
- IC-MPGN
Interventions
SGB-9768Drug
SGB-9768 for subcutaneous (SC) injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- change from baseline in urine protein-creatinine ratio (UPCR)Time frame: 24 weeks
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Peking University First Hospital
Beijing, China
Peking University People's Hospital
Beijing, China
The Third Xiangya Hospital of Central South University
Changsha, China
Sichuan Provincial People's Hospital
Chengdu, China
Guizhou Provincial People's Hospital
Guiyang, China
The affiliated hospital of Guizhou medical university
Guiyang, China
The first affiliated hospital, Zhejiang university school of medicine
Hangzhou, China
Huashan hospital
Shanghai, China
Northern Jiangsu People's Hospital
Yangzhou, China
General hospital of ningxia medical university
Yinchuan, China
Henan Provincial People's Hospital
Zhengzhou, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.